Cargando…
In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein
COVID 19 is a disease caused by a novel coronavirus, SARS-CoV2 originated in China most probably of Bat origin. Multiepitopes vaccine would be useful in eliminating SARS-CoV2 infections as asymptomatic patients are in large numbers. In response to this, we utilized bioinformatic tools to develop an...
Autor principal: | Kathwate, Gunderao H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722413/ https://www.ncbi.nlm.nih.gov/pubmed/35002585 http://dx.doi.org/10.1007/s10989-021-10348-z |
Ejemplares similares
-
Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein
por: Umitaibatin, Ramadhita, et al.
Publicado: (2023) -
Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis
por: Yazdani, Zahra, et al.
Publicado: (2020) -
In-silico design of a multi-epitope for developing sero-diagnosis detection of SARS-CoV-2 using spike glycoprotein and nucleocapsid antigens
por: Javadi Mamaghani, Amirreza, et al.
Publicado: (2021) -
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study
por: Yang, Zikun, et al.
Publicado: (2021) -
Multi-Epitope Vaccine Design Using an Immunoinformatic Approach for SARS-CoV-2
por: Feng, Ye, et al.
Publicado: (2021)